MyTherapy App and Charité Kick off Research Project on Post-Transplant Adherence

smartpatientCharité University of Berlin and the MyTherapy App step up their game collaborating on a new research project. A previous pilot study with Prof Elisabeth Steinhagen-Thiessen showed that MyTherapy has a positive impact on medication adherence among elderly patients. In a new research project starting 01 August 2016, kidney transplant patients will use MyTherapy as part of their post-transplant care routines. Under the leadership of Prof. Dr Klemens Budde, 100 patients will use the MyTherapy App over six months. The app (iOS und Android) will act as a support tool for the patients for adhering to their medication regimes, home measurements (e.g. blood pressure) as well as other treatment-related activities. The Charité researchers will evaluate the app’s effectiveness in comparison to a control group of the same size.

It is important especially for transplant patients to fully adhere to their prescribed medications, as the danger of complications after a transplant can otherwise increase. According to Prof Budde “every 1 in 6 kidneys is rejected due to poor adherence”. Prof Budde continues that “based on the positive study results from MyTherapy, we believe this app will help improve post-transplant outcomes”. The results of the study will be presented at an upcoming Nephrology Conference.

About MyTherapy
Keep track of your medications and stay on top of your health. The award-winning MyTherapy app reminds you of the medications you need to take and to get active by tracking your vitals and symptoms. MyTherapy’s built-in health journal summarises your medication and health information so you can oversee your health progress. You can share them with your healthcare provider, helping them better understand your needs or let your family be your safety net, in case you do forget a dose. MyTherapy keeps you in charge of your personal data at all times with strict privacy policies prohibiting the distribution to third parties. MyTherapy’s proven impact on medication adherence and its outstanding ease of usability for patients of all age groups has been demonstrated by several studies with reputable research institutes including Germany’s largest university hospital Charité Berlin. MyTherapy is available free of charge from the iTunes App Store and on Google Play.

For more information please visit: www.mytherapyapp.com

About smartpatient
smartpatient helps patients to take their medication and to implement a healthy lifestyle. Patients of a wide range of conditions and all ages trust smartpatient’s award-winning MyTherapy platform for managing their medication. Clinically evaluated and strictly protecting users’ privacy, MyTherapy stands out as the European answer to digitally supporting the chronically ill. Partners from academia and the healthcare industry rely on smartpatient for improving health outcomes. MyTherapy is available for free on the iTunes App Store and Google Play.

Sebastian Gaede, Philipp Legge and Julian Weddige founded smartpatient in late 2012. The Munich-based company received numerous awards for the MyTherapy platform and the underlying research. Lately smartpatient won the "Smart Service World" technology contest of the German Federal Ministry for Economic Affairs and Energy.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...